Camp4 Therapeutics Corp (CAMP) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $99K, and 4 sales totalling $2.5M. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Aug. 31, 2026 | Gold Kelly Chief Financial Officer | +$39,600 | 10,000 | New | No | |
|
|
||||||
| Aug. 31, 2026 filed Aug. 27, 2026 | Schwab Andrew J. Director | −$1,616,000 | 400,000 | −16% | No | |
|
|
||||||
| Aug. 26, 2026 filed Aug. 24, 2026 | Schwab Andrew J. Director | −$45 | 10 | −0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 19, 2026 | Schwab Andrew J. Director | −$879,719 | 191,865 | −7% | No | |
|
|
||||||
| Aug. 19, 2026 | Tardiff Daniel Chief Scientific Officer | −$8,273 | 1,738 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free